BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32565486)

  • 1. Prognostic value of lymphovascular space invasion in early-stage cervical cancer.
    Weyl A; Illac C; Lusque A; Leray H; Vaysse C; Martinez A; Chantalat E; Motton S
    Int J Gynecol Cancer; 2020 Oct; 30(10):1493-1499. PubMed ID: 32565486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of lymph vascular space invasion on prognosis of patients with early-stage cervical squamous cell carcinoma.
    Yan M; Zhang YN; He JH; Sun JR; Sun XM
    Chin J Cancer; 2010 Apr; 29(4):425-30. PubMed ID: 20346220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Satellite lymphovascular space invasion: An independent risk factor in early stage cervical cancer.
    Pol FJ; Zusterzeel PL; van Ham MA; Kuijpers DA; Bulten J; Massuger LF
    Gynecol Oncol; 2015 Sep; 138(3):579-84. PubMed ID: 26126782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of lymphovascular space invasion for stage IA1 and IA2 cervical cancer.
    Margolis B; Cagle-Colon K; Chen L; Tergas AI; Boyd L; Wright JD
    Int J Gynecol Cancer; 2020 Jun; 30(6):735-743. PubMed ID: 32179697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy.
    Gülseren V; Kocaer M; Çakır İ; Özdemir İA; Sancı M; Güngördük K
    J Obstet Gynaecol; 2020 Jul; 40(5):699-704. PubMed ID: 31607197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of satellite-lymphovascular space involvement in early-stage cervical cancer.
    Herr D; König J; Heilmann V; Koretz K; Kreienberg R; Kurzeder C
    Ann Surg Oncol; 2009 Jan; 16(1):128-32. PubMed ID: 18979136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of lymphovascular space invasion in patients with early stage cervical cancer in Jilin, China: A retrospective study.
    Yan W; Qiu S; Ding Y; Zhang Q; Si L; Lv S; Liu L
    Medicine (Baltimore); 2019 Oct; 98(40):e17301. PubMed ID: 31577720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does a uterine manipulator affect cervical cancer pathology or identification of lymphovascular space involvement?
    Rakowski JA; Tran TA; Ahmad S; James JA; Brudie LA; Pernicone PJ; Radi MJ; Holloway RW
    Gynecol Oncol; 2012 Oct; 127(1):98-101. PubMed ID: 22800652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy.
    Takeda N; Sakuragi N; Takeda M; Okamoto K; Kuwabara M; Negishi H; Oikawa M; Yamamoto R; Yamada H; Fujimoto S
    Acta Obstet Gynecol Scand; 2002 Dec; 81(12):1144-51. PubMed ID: 12519111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical treatment of microinvasive cervical cancer: analysis of pathologic features with implications on radicality.
    Yoneda JY; Braganca JF; Sarian LO; Borba PP; Conceição JC; Zeferino LC
    Int J Gynecol Cancer; 2015 May; 25(4):694-8. PubMed ID: 25742569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy versus chemoradiotherapy for FIGO stages IB1 and IIA1 cervical squamous cancer patients with lymphovascular space invasion: a retrospective study.
    Zhang H; Yu R; Zhang L; Wang R; Xiao L
    BMC Cancer; 2022 Feb; 22(1):202. PubMed ID: 35193525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic Factors of Cervical Adenocarcinoma Stages IB to IIB.
    Mabuchi Y; Yahata T; Kobayashi A; Tanizaki Y; Shiro M; Ota N; Yagi S; Minami S; Ino K
    Int J Gynecol Cancer; 2015 Nov; 25(9):1677-82. PubMed ID: 26495760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safe criteria for less radical trachelectomy in patients with early-stage cervical cancer: a multicenter clinicopathologic study.
    Kim HS; Choi CH; Lim MC; Chang SJ; Kim YB; Kim MA; Kim TJ; Park SY; Kim BG; Song YS; Bae DS; Kim JW
    Ann Surg Oncol; 2012 Jun; 19(6):1973-9. PubMed ID: 22183162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical cancer with ≤5 mm depth of invasion and >7 mm horizontal spread - Is lymph node assessment only required in patients with LVSI?
    Wenzel HHB; Van Kol KGG; Nijman HW; Lemmens VEPP; Van der Aa MA; Ebisch RMF; Bekkers RLM
    Gynecol Oncol; 2020 Aug; 158(2):282-286. PubMed ID: 32381363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of treatment modalities and prognosis on microinvasive cervical cancer: a 10-year cohort study in China.
    Qian Q; Yang J; Cao D; You Y; Chen J; Shen K
    J Gynecol Oncol; 2014 Oct; 25(4):293-300. PubMed ID: 25142622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential for less radical surgery in women with stage IA2-IB1 cervical cancer.
    Bai H; Yuan F; Wang H; Chen J; Cui Q; Shen K
    Int J Gynaecol Obstet; 2015 Sep; 130(3):235-40. PubMed ID: 26070225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in FIGO stage IB cervical cancer without lymph node metastasis and the role of adjuvant radiotherapy after radical hysterectomy.
    Ayhan A; Al RA; Baykal C; Demirtas E; Ayhan A; Yüce K
    Int J Gynecol Cancer; 2004; 14(2):286-92. PubMed ID: 15086728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locoregional spread and survival of stage IIA1 versus stage IIA2 cervical cancer.
    Hongladaromp W; Tantipalakorn C; Charoenkwan K; Srisomboon J
    Asian Pac J Cancer Prev; 2014; 15(2):887-90. PubMed ID: 24568513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extent of lymphovascular space invasion and risk of pelvic lymph node metastases in stage IB1 cervical cancer.
    Chandacham A; Charoenkwan K; Siriaunkgul S; Srisomboon J; Suprasert P; Phongnarisorn C; Cheewakraingkrai C; Siriaree S; Tantipalakorn C; Kietpeerakool C
    J Med Assoc Thai; 2005 Oct; 88 Suppl 2():S31-6. PubMed ID: 17722314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parametrial involvement in women with low-risk, early-stage cervical cancer.
    Vanichtantikul A; Tantbirojn P; Manchana T
    Eur J Cancer Care (Engl); 2017 Sep; 26(5):. PubMed ID: 27704641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.